Global Human Native Antigens and Recombinant Antigens Revenue is Expected to Grow to 251.92 M USD by 2028

An antigen is defined as being any substance capable of inducing an immune response which results in the production of antibodies. Naturally-occurring antigens include proteins derived from microbial organisms; bacterial toxins; and non-microbial substances such as pollen, egg white or incompatible blood cells. Many antigens may be produced artificially.

Widely employed within immunization programs to generate antibodies for commercialization, both native and recombinant antigens are used as essential controls within diagnostic and prognostic testing. Both forms also have considerable utility as standards in a wide range of applications.

Clinical Biochemistry is the division of laboratory medicine that deals with the measurement of chemicals (both natural and unnatural) in blood, urine and other body fluids. These test results are useful for detecting health problems, determining prognosis and guiding the therapy of a patient.

Global Human Native Antigens and Recombinant Antigens revenue in 2022 was 167.96 M USD, it is expected to grow to 251.92 M USD by 2028, the CAGR is 6.99% from 2022-2028.

Key Players Analysis

Human Native Antigens and Recombinant Antigens market companies are mainly from Europe and USA; the industry concentrate rate is very high. The top three companies are Meridian Life Science, BBI Solutions and Fapon Biotech Inc.

Meridian Life Science is one of the major players operating in the Human Native Antigens and Recombinant Antigens market, holding a share of 21.61% in 2020.Meridian Life Science, Inc. is a leading large scale manufacturer of antibodies, viral antigens, recombinant proteins, PCR Enzymes, nucleotides and critical assay reagents. The company\'s focus is to offer products and services that help to advance the development of diagnostic assays.

Meridian Life Science Outlook
Company Name	Meridian Life Science
Website	meridianlifescience.com
Established Time	1977
Plants Distribution	Mainly in North America
Sales Region	Worldwide
Business Overview	Meridian Life Science, Inc. is a leading large scale manufacturer of antibodies, viral antigens, recombinant proteins, PCR Enzymes, nucleotides and critical assay reagents. The company\'s focus is to offer products and services that help to advance the development of diagnostic assays.